NCT06808503 NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
| NCT ID | NCT06808503 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West Virginia University |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-10-02 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-10-02 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate. Investigators aim to do the following: 1. Gather formative data from providers, parents, and youth to inform ways to adapt and implement the NIMH Clinical Pathway so that it can be effectively implemented in rural, Appalachian School-Based Health Centers (SBHCs). 2. Gather preliminary data regarding the feasibility, acceptability, and effectiveness of the adapted intervention.
Eligibility Criteria
Inclusion Criteria: * Youth who are receiving services at the school-based health centers to participate * Parents must be able to give legal consent for themselves and their children to participate * Youth and Parent must be English-speaking * Youth must also be able to give signed assent to participate * Youth must be cognitively and medically able to participate in study activities Exclusion Criteria: * Youth in state custody will be excluded from study participation due to challenges related to obtaining legal consent.
Contact & Investigator
Mary Christensen, PhD, LICSW
PRINCIPAL INVESTIGATOR
West Virginia University
Frequently Asked Questions
Who can join the NCT06808503 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06808503 currently recruiting?
Yes, NCT06808503 is actively recruiting participants. Contact the research team at mary.christensen@mail.wvu.edu for enrollment information.
Where is the NCT06808503 trial being conducted?
This trial is being conducted at Morgantown, United States.
Who is sponsoring the NCT06808503 clinical trial?
NCT06808503 is sponsored by West Virginia University. The principal investigator is Mary Christensen, PhD, LICSW at West Virginia University. The trial plans to enroll 30 participants.